H.R. 4284 — what changed
Indexing Narcotics, Fentanyl, and Opioids Act of 2018
From Introduced in House to Engrossed in House. 2 sections amended and 1 added between Introduced in House and Engrossed in House.
Section 1 Short title
changed
This Act may be cited as the “Indexing Narcotics, Fentanyl, and Opioids Act of 2017” 2018” or the “INFO Act”.
Sec. 2 Establishment of substance use disorder information dashboard
added Title XVII of the Public Health Service Act (42 U.S.C. 300u et seq.) is amended by adding at the end the following new section:
added “1711. Establishment of substance use disorder information dashboard
added “(a) In general—Not later than 6 months after the date of the enactment of this section, the Secretary of Health and Human Services shall, in consultation with the Director of National Drug Control Policy, establish and periodically update a public information dashboard that—
added “(1) coordinates information on programs within the Department of Health and Human Services related to the reduction of opioid abuse and other substance use disorders;
added “(2) provides access to publicly available data from other Federal agencies; State, local, and Tribal governments; nonprofit organizations; law enforcement; medical experts; public health educators; and research institutions regarding prevention, treatment, recovery, and other services for opioid use disorder and other substance use disorders;
added “(3) provides comparable data on substance use disorder prevention and treatment strategies in different regions and population of the United States;
added “(4) provides recommendations for health care providers on alternatives to controlled substances for pain management, including approaches studied by the National Institutes of Health Pain Consortium and the National Center for Complimentary and Integrative Health; and
added “(5) provides guidelines and best practices for health care providers regarding treatment of substance use disorders.
added “(b) Controlled substance defined—In this section, the term “controlled substance” has the meaning given that term in section 102 of the Controlled Substances Act (21 U.S.C. 802).”
removed
In general— Not later than 60 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall appoint a Federal Coordinator for the Department of Health and Human Services to carry out the duties described in subsection (b).
removed
Duties— The Federal Coordinator shall—
removed
coordinate programs within the Department of Health and Human Services that relate to opioid abuse reduction;
removed
serve as a liaison to State and local governments and entities carrying out activities relating to opioid abuse reduction pursuant to a Federal contract or grant; and
removed
in consultation with the United States Attorney General, the Secretary of Veterans Affairs, the Director of the Office of National Drug Control Policy, and any other individual that the Federal Coordinator determines appropriate, establish and operate a publicly available electronic database through which the Federal Coordinator shall carry out the following:
removed
Collect data on opioid abuse from Federal agencies; State, local, and Tribal governments; nonprofit organizations; law enforcement; medical experts; public health educators; and research institutions.
removed
Publish a comprehensive list of Federal funding resources available to States for research on opioid abuse.
removed
Analyze causes and trends behind opioid addiction and pain management.
removed
Evaluate the effectiveness of Federal programs for opioid abuse reduction, including opioid treatment programs and medicated-assisted treatments.
removed
Evaluate whether any Federal programs for opioid abuse reduction are duplicative.
removed
Evaluate the extent to which Federal grants for the implementation of opioid abuse prevention strategies are successful in addressing opioid abuse in local communities.
removed
Provide recommendations to health care providers on alternatives to opioids for pain management and other areas in which health care providers can improve with respect to treating or preventing opioid abuse.
removed
Analyze opioid prescription guidelines, the different types of opioids prescribed by health care providers, and the use of medicated-assisted treatments.
removed
Compare the rate of opioid abuse in veterans receiving health care through the Department of Veterans Affairs with the rate of opioid abuse in the general population.
removed
Compare opioid abuse trends and prevention and treatment strategies in different regions and populations of the United States and determine whether certain strategies are more effective than others.
removed
Analyze to what extent Federal prevention and treatment strategies for opioid abuse are aligned with State and local prevention and treatment strategies.
removed
Reports—
removed
Initial report— Not later than one year after the date of the enactment of this section, the Federal Coordinator shall submit to Congress an initial report on the results of any analysis, evaluation, or comparison conducted under subsection (b)(3).
removed
Updated report— Not later than five years after the date of the enactment of this section, the Federal Coordinator shall submit to Congress a report that provides updates with respect to any results submitted in the initial report under paragraph (1).
removed
Public availability— Each report submitted under this subsection shall be made publicly available on the electronic database established under subsection (b)(3).
Sec. 3 Interagency Substance Use Disorder Coordinating Committee
added
added
Establishment— Not later than 3 months after the date of the enactment of this Act, the Secretary of Health and Human Services (in this section referred to as the “Secretary”) shall, in consultation with the Director of National Drug Control Policy, establish a committee, to be known as the Interagency Substance Use Disorder Coordinating Committee (in this section referred to as the “Committee”), to coordinate all efforts within the Department of Health and Human Services concerning substance use disorder.
added
Membership—
added
Federal members— The following individuals shall be the Federal members of the Committee:
added
The Secretary, who shall service as the Chair of the Committee.
added
The Attorney General of the United States.
added
The Secretary of Labor.
added
The Secretary of Housing and Urban Development.
added
The Secretary of Education.
added
The Secretary of Veterans Affairs.
added
The Commissioner of Social Security.
added
The Assistant Secretary for Mental Health and Substance Use.
added
The Director of the Centers for Disease Control and Prevention.
added
The Director of the National Institutes of Health and the Directors of such national research institutes of the National Institutes of Health as the Secretary determines appropriate.
added
The Administrator of the Centers for Medicare & Medicaid Services.
added
The Director of National Drug Control Policy.
added
Representatives of other Federal agencies that serve individuals with substance use disorder.
added
Non-Federal members— The Committee shall include a minimum of 17 non-Federal members appointed by the Secretary, of which—
added
at least two such members shall be an individual who has received treatment for a diagnosis of an opioid use disorder;
added
at least two such members shall be an individual who has received treatment for a diagnosis of a substance use disorder other than an opioid use disorder;
added
at least two such members shall be a State Alcohol and Substance Abuse Director;
added
at least two such members shall be a representative of a leading research, advocacy, or service organization for adults with substance use disorder;
added
at least two such members shall—
added
be a physician, licensed mental health professional, advance practice registered nurse, or physician assistant; and
added
have experience in treating individuals with opioid use disorder or other substance use disorders;
added
at least one such member shall be a substance use disorder treatment professional who is employed with an opioid treatment program;
added
at least one such member shall be a substance use disorder treatment professional who has research or clinical experience in working with racial and ethnic minority populations;
added
at least one such member shall be a substance use disorder treatment professional who has research or clinical mental health experience in working with medically underserved populations;
added
at least one such member shall be a State-certified substance use disorder peer support specialist;
added
at least one such member shall be a drug court judge or a judge with experience in adjudicating cases related to substance use disorder;
added
at least one such member shall be a law enforcement officer or correctional officer with extensive experience in interacting with adults with a substance use disorder; and
added
at least one such member shall be an individual with experience providing services for homeless individuals and working with adults with a substance use disorder.
added
Terms—
added
In general— A member of the Committee appointed under subsection (b)(2) shall be appointed for a term of 3 years and may be reappointed for one or more 3-year terms.
added
Vacancies— A vacancy on the Committee shall be filled in the same manner in which the original appointment was made. Any individual appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of such term and may serve after the expiration of such term until a successor has been appointed.
added
Meetings— The Committee shall meet not fewer than two times each year.
added
Duties— The Committee shall—
added
monitor opioid use disorder and other substance use disorder research, services, and support and prevention activities across all relevant Federal agencies, including coordination of Federal activities with respect to opioid use disorder and other substance use disorders;
added
identify and provide to the Secretary recommendations for improving Federal grants and programs for the prevention and treatment of, and recovery from, opioid use disorder and other substance use disorders;
added
review substance use disorder prevention and treatment strategies in different regions and populations in the United States and evaluate the extent to which Federal substance use disorder prevention and treatment strategies are aligned with State and local substance use disorder prevention and treatment strategies;
added
make recommendations to the Secretary regarding any appropriate changes with respect to the activities and strategies described in paragraphs (1) through (3);
added
make recommendations to the Secretary regarding public participation in decisions relating to opioid use disorder and other substance use disorders and the process by which public feedback can be better integrated into such decisions; and
added
make recommendations to ensure that opioid use disorder and other substance use disorder research, services, and support and prevention activities of the Department of Health and Human Services and other Federal agencies are not unnecessarily duplicative.
added
Annual report—
added
In general— Not later than 1 year after the date of the enactment of this Act, and annually thereafter for the life of the Committee, the Committee shall publish on the public information dashboard established under section 2(a) a report summarizing the activities carried out by the Committee pursuant to subsection (e), including any findings resulting from such activities.
added
Recommendation for Committee extension— After the publication of the second report of the Committee under paragraph (1), the Secretary shall submit to Congress a recommendation on whether or not the operations of the Committee should continue after the termination date described in subsection (i).
added
Working groups— The Committee may establish working groups for purposes of carrying out the duties described in subsection (e). Any such working group shall be composed of members of the Committee (or the designees of such members) and may hold such meetings as are necessary to enable the working group to carry out the duties delegated to the working group.
added
Federal Advisory Committee Act— The Federal Advisory Committee Act (5 U.S.C. App.) shall apply to the Committee only to the extent that the provisions of such Act do not conflict with the requirements of this section.
added
Sunset— The Committee shall terminate on the date that is 6 years after the date on which the Committee is established under subsection (a).